In this edition of Health Action International’s ‘Staff Spotlight’, we talk to Sabrina over her typical ramen-noodle lunch about living the #HAILife and making change in the world of snakebite.
by MAARTEN VAN DER HEIJDEN, Policy Associate, ReAct – Action on Antibiotic Resistance
Last week, the Second Consultation of Member States and Partners on the Global Development and Stewardship Framework to Combat Antimicrobial Resistance (AMR) took place. Like the last meeting in November 2017, non-state actors were invited to participate in the first of the meeting,
by ALEX LAWRENCE, Communications Advisor
At the 71st World Health Assembly, the great and the good (and sometimes, not so good) of global health came together on some of the most pressing health challenges we face.
On the agenda, and of particular interest to Health Action International (HAI), were the World Health Organization’s (WHO) General Programme of Work (GPW13),
by ANCEL.LA SANTOS, Senior Policy Advisor
The formal engagement of patients and consumers in the pharmaceutical regulatory process helps ensure that important decisions about medicines take into account the thoughts and views of the people they most affect. The European Medicines Agency (EMA) has a long tradition of this kind of stakeholder involvement.
A famous man, John Quincy Adams, once said, “If your actions inspire others to dream more, learn more, do more and become more, you are a leader”. Mr Adams was the sixth president of the United States of America—and the first to give an interview to a female journalist, Anne Royall, which was quite progressive for his time.
Health Action International Presents “Minutes to Die” at the Dutch Global Health Film Festival
by BIRTE BOGATZ, Communications Advisor
by THE HSA4A PARTNERSHIP
Maternal mortality is the number one cause of death in sub-Saharan Africa. Despite the fact that maternal mortality is high on the international agenda, the goal to reduce maternal mortality by 75 percent by 2015, is still far from being reached. By advocating and influencing the availability of affordable medicines and contraception and increasing the availability and accessibility of skilled health workers,
By LEAH COWAN
On 19 July, over 150 participants from consumer groups, policy and research bodies, universities and NGOs attended the annual Global Health Conference at the University of Sussex: ‘Pharmaceuticals and Global Health – Inequalities and Innovation in the 21st Century’. It was a pleasure to return to one of Britain’s greenest and beautifully-located campuses,
By ANCEL.LA SANTOS QUINTANO
On 29 May 2013 the European Parliament’s Environment, Public Health and Food Safety (ENVI) Committee voted unanimously in favour of a draft body of rules governing the authorisation and conduct of clinical trials in the EU. HAI Europe welcomes advancements in this legislative process towards increased access to clinical trial data but notes that more needs to be done.